Trial intelligence / Profile preview

Libramed in Obese Children

NCT02148614Phase 2Unknown

Sponsor
Azienda Ospedaliera Universitaria Integrata Verona
Start
Jan 2014
Primary completion
Sep 2021
Countries
1
01

Overview

Phase 2, randomised, double-blind trial (4 arms), sponsored by Azienda Ospedaliera Universitaria Integrata Verona. Primary endpoint: Area under the curve of plasma glucose at 4 hours. Status: unknown.

Beyond the preview

Go deeper on NCT02148614.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02148614.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call